CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacogenomics and Personalized Medicine"
DOI: 10.2147/pgpm.s181334
Abstract: Background Opioids are widely used for chronic low back pain (CLBP); however, it is still unclear how to predict their effectiveness and safety. Codeine, tramadol and oxycodone are metabolized by CYP/CYP450 2D6 (CYP2D6), a highly… read more here.
Keywords: effectiveness safety; predict effectiveness; treatment; cyp2d6 ... See more keywords